The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

cardion.de

Founded Year

1996

Stage

Asset Sale | AssetsPurchased

Total Raised

$55.19M

About Cardion

Developer of novel therapeutics for applications in the treatment of inflammatory and autoimmune disorders, as well as related disease conditions. These include rheumatoid arthritis, Crohn's disease, diabetes, transplant rejection, as well as targeted therapies of immune-system cell cancers such as multiple myeloma. These include rheumatoid arthritis, Crohn's disease, diabetes, and transplant rejection, as well as targeted therapies of immune-system cell cancers such as multiple myeloma. The company is focusing on three rapidly growing product fields: a novel immunotherapeutic protein for the treatment of Rheumatoid Arthritis and other Inflammatory diseases; gene and protein therapy for the ischemic cardiovascular disease and congestive heart failure (CHF); and stem cell therapy for the treatment of Type I diabetes and CHF. The company integrates stem cell-technology, tolerance induction, and non-viral local gene therapy to support a balanced pipeline of product candidates in the cardiovascular and autoimmunity franchise.

Cardion Headquarter Location

Max-Planck-Strasse 15a

Erkrath, 40699,

Germany

49 211 20565 0

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cardion

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cardion is included in 2 Expert Collections, including Diabetes.

D

Diabetes

1,750 items

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Cardion Patents

Cardion has filed 1 patent.

The 3 most popular patent topics include:

  • Cardiac arrhythmia
  • Cardiac electrophysiology
  • Cardiac procedures
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/25/2020

Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Cardiac procedures, Heart diseases

Application

Application Date

11/25/2020

Grant Date

Title

Related Topics

Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Cardiac procedures, Heart diseases

Status

Application

Latest Cardion News

Implantable Loop Recorders Market Size to Grow by USD 606.31 Mn| 39% of the growth to originate from North America| Technavio

Feb 24, 2022

| Technavio News provided by Share this article Share this article NEW YORK, Feb. 24, 2022 /PRNewswire/ -- The latest Implantable Loop Recorders Market research report by Technavio infers that the growing number of cardiac conditions due to irregularity in heart rhythms and other chronic diseases is driving this market's growth. Resulting in market growth of USD 606.31 million from 2021 to 2026, read additional information about the market,  get FREE sample report . Attractive Opportunities in Implantable Loop Recorders Market by Application and Geography - Forecast and Analysis 2022-2026 Vendor Landscape The market structure is expected to remain fragmented during the forecast period. Vendors are deploying different organic and inorganic growth strategies to compete in the market. Abbott Laboratories, Angel Medical Systems Inc., Asian Heart and Vascular Centre, BIOTRONIK SE and Co. KG, Boston Scientific Corp., CARDION sro, Medtronic Plc, TechIndia Infoway Pvt. Ltd., Vectorious Medical Technologies Ltd. among others are some of the few key vendors competing to maintain their market position in the market. Various players in the market are engaging in strategic partnerships and joint ventures coupled with launching differentiated products to up their game in the medical technology and device industry. For instance, in January 2020, CardioComm Solutions Inc. entered into a partnership agreement with CareOS SAS, a subsidiary of Baracoda Group, to provide consumer ECG monitoring technologies through the CareOS Poseidon smart mirror health and beauty hub. View more  about the market's vendor landscape highlights with a comprehensive list of vendors and their offerings. Key Market Segmentation Regional Market Outlook North America will contribute to 39% of the market growth during the forecast period. The growth of this region can be attributed to the increase in the prevalence of cardiovascular diseases, coronary artery disease, peripheral artery disease, and stroke. Apart from regions, if we look at the country-wise market growth, the US, Canada, Spain, Denmark, China, and UK will contribute to the highest market growth. Download our FREE sample report  for more key highlights on the regional market share of most of the above-mentioned countries. Latest Trends, Driving the Global Home Textile Retail Market Market Driver: Growing number of cardiac conditions due to irregularity in heart rhythms: Every year, approximately 209,000 patients in the United States are treated for in-hospital cardiac arrest, according to the Centers for Disease Control and Prevention (CDC). Arrhythmia can be exacerbated by other illnesses such as chronic liver and renal disease, as well as thyroid problems. According to the CDC, chronic kidney disease affects over 15% of adults in the United States, or nearly 37 million individuals (CKD). Every hour, roughly 340 people receive dialysis therapy for kidney failure, according to the CDC. The majority of ESRD patients who get hemodialysis suffer from cardiac arrest and arrhythmia. As a result, rising demand for arrhythmia monitoring devices like ILR is expected to drive market expansion throughout the forecast period. Market Trend: The supportive government and non-government initiative: Governments all across the world are concerned about the rise in cardiovascular disease cases. Furthermore, half of the world's population resides in rural areas, and nations like Spain, China, Thailand, and India are focusing on improving access to healthcare in these areas. As a result, the medical technology and device business is collaborating with government and non-governmental organizations to address the worrying state of people's health. Find additional information about various other market drivers & trends mentioned in our FREE sample report . Want to understand more about the various research methodology? Evaluate a specific segment or region in detail Identify key suppliers, customers, or other market players Analyze market regulations Tailor this report according to your needs. Get it done with our $1000 worth of free customization. Speak to Our Analyst Now ! Related Reports:                4.2 Bargaining power of buyers                                           Exhibit 16: Bargaining power of buyers                4.3 Bargaining power of suppliers                                       Exhibit 17: Bargaining power of suppliers                4.4 Threat of new entrants                                    Exhibit 18: Threat of new entrants                4.5 Threat of substitutes                          4.6 Threat of rivalry                   4.7 Market condition  5 Market Segmentation by Application                                        5.1 Market segments                5.2 Comparison by Application                             5.3 Cardiac arrhythmia - Market size and forecast 2021-2026                                 Exhibit 24:  Cardiac arrhythmia - Market size and forecast 2021-2026 ($ million)                               Exhibit 25:  Cardiac arrhythmia - Year-over-year growth 2021-2026 (%)                5.4 Atrial fibrillation - Market size and forecast 2021-2026                                      Exhibit 26:  Atrial fibrillation - Market size and forecast 2021-2026 ($ million)                               Exhibit 27:  Atrial fibrillation - Year-over-year growth 2021-2026 (%)                5.5 Market opportunity by Application                                             Exhibit 28:  Market opportunity by Application 6. Customer landscape                                        6.1 Overview                               Technavio's customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria                               Exhibit 29: Customer landscape                               Exhibit 32:  North America - Market size and forecast 2021-2026 ($ million)                               Exhibit 33:  North America - Year-over-year growth 2021-2026 (%)                7.4 Europe - Market size and forecast 2021-2026                                        Exhibit 34:   Europe - Market size and forecast 2021-2026 ($ million)                               Exhibit 35:  Europe - Year-over-year growth 2021-2026 (%)                7.5 Asia - Market size and forecast 2021-2026                               Exhibit 36:   Asia - Market size and forecast 2021-2026 ($ million)                               Exhibit 37:  Asia - Year-over-year growth 2021-2026 (%)                7.6 ROW - Market size and forecast 2021-2026                                            Exhibit 38:  ROW - Market size and forecast 2021-2026 ($ million)                               Exhibit 39:  ROW - Year-over-year growth 2021-2026 (%)                7.7 Key leading countries                        7.8 Market opportunity by geography                               Exhibit 41: Market opportunity by geography 8. Drivers, Challenges, and Trends                                  8.1 Market drivers                                     8.1.2 Growing awareness initiatives and access to healthcare                               8.1.3 Technological advances and new product launches                8.2 Market challenges                                             Exhibit 47: Market positioning of vendors                10.3 Abbott Laboratories                                       Exhibit 49:  Abbott Laboratories  - Business segments                               Exhibit 50:  Abbott Laboratories  - Key News                               Exhibit 51:  Abbott Laboratories  - Key offerings                               Exhibit 52:  Abbott Laboratories  - Segment focus                10.4 Angel Medical Systems Inc.                                         Exhibit 53:  Angel Medical Systems Inc. - Overview                               Exhibit 54:  Angel Medical Systems Inc. - Product and service                               Exhibit 55:  Angel Medical Systems Inc. - Key offerings                10.5 Asian Heart and Vascular Centre                                Exhibit 56:  Asian Heart and Vascular Centre - Overview                               Exhibit 57:  Asian Heart and Vascular Centre - Product and service                               Exhibit 58:  Asian Heart and Vascular Centre - Key offerings                10.6 BIOTRONIK SE and Co. KG                                            Exhibit 59:  BIOTRONIK SE and Co. KG - Overview                               Exhibit 60:  BIOTRONIK SE and Co. KG - Product and service                               Exhibit 61:  BIOTRONIK SE and Co. KG - Key offerings                10.7 Boston Scientific Corp.                                  Exhibit 63:  Boston Scientific Corp. - Business segments                               Exhibit 64:  Boston Scientific Corp. - Key News                               Exhibit 65:  Boston Scientific Corp. - Key offerings                               Exhibit 66:  Boston Scientific Corp. - Segment focus                10.8 CARDION sro                                     Exhibit 68:  CARDION sro - Product and service                               Exhibit 69:  CARDION sro - Key offerings                10.9 Medtronic Plc                                   Exhibit 71:  Medtronic Plc - Business segments                               Exhibit 72:  Medtronic Plc - Key offerings                               Exhibit 73:  Medtronic Plc - Segment focus                10.10 TechIndia Infoway Pvt. Ltd.                                       Exhibit 74:  TechIndia Infoway Pvt. Ltd. - Overview                               Exhibit 75:  TechIndia Infoway Pvt. Ltd. - Product and service                               Exhibit 76:  TechIndia Infoway Pvt. Ltd. - Key offerings                10.11 Vectorious Medical Technologies Ltd.                                  Exhibit 77:  Vectorious Medical Technologies Ltd. - Overview                               Exhibit 78:  Vectorious Medical Technologies Ltd. - Product and service                               Exhibit 79:  Vectorious Medical Technologies Ltd. - Key offerings 11. Appendix                                                          11.1.1 Market definition About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

  • When was Cardion founded?

    Cardion was founded in 1996.

  • Where is Cardion's headquarters?

    Cardion's headquarters is located at Max-Planck-Strasse 15a, Erkrath.

  • What is Cardion's latest funding round?

    Cardion's latest funding round is Asset Sale.

  • How much did Cardion raise?

    Cardion raised a total of $55.19M.

  • Who are the investors of Cardion?

    Investors of Cardion include Roche Venture Fund, TVM Capital Life Science, IKB Private Equity, Deutsche Venture Capital, BDW and 9 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.